Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thinzar Min

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
American Journal of Surgery|April 4, 2026
Uncovering molecular pathways in appendiceal cancer: A comprehensive characterization for precision oncologyThinzar Min Lwin, Brigette Waldrup, Francisco G Carranza, et al.
Primary Care Diabetes|January 15, 2023
Freestyle libre use in people with type 2 diabetes using basal-bolus insulin is associated with improved glycaemic control: A real-world analysisDavid M Williams, Elin Crockett, Su Aye, et al.
Metabolism: Clinical and Experimental|September 21, 2015
Association between the preoperative fasting and postprandial C-peptide AUC with resolution of type 2 diabetes 6 months following bariatric surgeryAkhila Mallipedhi, Thinzar Min, Sarah L Prior, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|December 16, 2024
Removing barriers to management of adults with type 2 diabetes on insulin using continuous glucose monitoring in UK primary care practice: An expert consensusSamuel Seidu, Lorraine Avery, Heather Bell, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|February 10, 2021
Real-World Clinical Experience of Semaglutide in Secondary Care Diabetes: A Retrospective Observational StudyDavid M Williams, Aliya M Ruslan, Rahim Khan, et al.
BMJ Open|April 15, 2025
Impact of real-time glucose monitoring using FreeStyle Libre 3 on glycaemia in type 2 diabetes managed with basal insulin plus SGLT2 inhibitor and/or GLP-1 agonist: the FreeDM2 randomised controlled trial protocolEmma G Wilmot, Ramzi A Ajjan, Yee S Cheah, et al.
The Lancet. Diabetes & Endocrinology|April 26, 2026
Continuous glucose monitoring versus self-monitoring of blood glucose in individuals with type 2 diabetes: a randomised, multicentre, open-label, superiority trialEmma G Wilmot, Patrick Moore, Thozhukat Sathyapalan, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
American Journal of Surgery|April 4, 2026
Uncovering molecular pathways in appendiceal cancer: A comprehensive characterization for precision oncologyThinzar Min Lwin, Brigette Waldrup, Francisco G Carranza, et al.
Primary Care Diabetes|January 15, 2023
Freestyle libre use in people with type 2 diabetes using basal-bolus insulin is associated with improved glycaemic control: A real-world analysisDavid M Williams, Elin Crockett, Su Aye, et al.
Metabolism: Clinical and Experimental|September 21, 2015
Association between the preoperative fasting and postprandial C-peptide AUC with resolution of type 2 diabetes 6 months following bariatric surgeryAkhila Mallipedhi, Thinzar Min, Sarah L Prior, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|December 16, 2024
Removing barriers to management of adults with type 2 diabetes on insulin using continuous glucose monitoring in UK primary care practice: An expert consensusSamuel Seidu, Lorraine Avery, Heather Bell, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|February 10, 2021
Real-World Clinical Experience of Semaglutide in Secondary Care Diabetes: A Retrospective Observational StudyDavid M Williams, Aliya M Ruslan, Rahim Khan, et al.
BMJ Open|April 15, 2025
Impact of real-time glucose monitoring using FreeStyle Libre 3 on glycaemia in type 2 diabetes managed with basal insulin plus SGLT2 inhibitor and/or GLP-1 agonist: the FreeDM2 randomised controlled trial protocolEmma G Wilmot, Ramzi A Ajjan, Yee S Cheah, et al.
The Lancet. Diabetes & Endocrinology|April 26, 2026
Continuous glucose monitoring versus self-monitoring of blood glucose in individuals with type 2 diabetes: a randomised, multicentre, open-label, superiority trialEmma G Wilmot, Patrick Moore, Thozhukat Sathyapalan, et al.
Pageof 4